Case Number:

IPR2022-00608

Case Type:

IPR

Status:

Final Written Decision - Appealed

Petitioner:

Penumbra, Inc.

Patent Owner:

Tech Center:

1. Filed: February 15, 2022 00:00

   Coverage

   1. September 08, 2023

      PTAB Axes RapidPulse Blood Clot Removal Patent

      The Patent Trial and Appeal Board has found medical device company Penumbra Inc. was able to show that numerous claims in a patent on a treatment for strokes caused by blood clots were invalid, saying the claims were obvious.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login